Literature DB >> 25547680

Ocular herpes: the pathophysiology, management and treatment of herpetic eye diseases.

Lucy Zhu1, Hua Zhu.   

Abstract

Herpesviruses are a prominent cause of human viral disease, second only to the cold and influenza viruses. Most herpesvirus infections are mild or asymptomatic. However, when the virus invades the eye, a number of pathologies can develop and its associated sequelae have become a considerable source of ocular morbidity. The most common culprits of herpetic eye disease are the herpes simplex virus (HSV), varicella zoster virus (VZV), and cytomegalovirus (CMV). While primary infection can produce ocular disease, the most destructive manifestations tend to arise from recurrent infection. These recurrent infections can wreck devastating effects and lead to irreversible vision loss accompanied by a decreased quality of life, increased healthcare usage, and significant cost burden. Unfortunately, no method currently exists to eradicate herpesviruses from the body after infection. Treatment and management of herpes-related eye conditions continue to revolve around antiviral drugs, although corticosteroids, interferons, and other newer therapies may also be appropriate depending on the disease presentation. Ultimately, the advent of effective vaccines will be crucial to preventing herpesvirus diseases altogether and cutting the incidence of ocular complications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547680      PMCID: PMC8206444          DOI: 10.1007/s12250-014-3539-2

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  92 in total

1.  Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.

Authors:  Heather Bradley; Lauri E Markowitz; Theda Gibson; Geraldine M McQuillan
Journal:  J Infect Dis       Date:  2013-10-16       Impact factor: 5.226

2.  Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial.

Authors:  Michael S Simberkoff; Robert D Arbeit; Gary R Johnson; Michael N Oxman; Kathy D Boardman; Heather M Williams; Myron J Levin; Kenneth E Schmader; Lawrence D Gelb; Susan Keay; Kathleen Neuzil; Richard N Greenberg; Marie R Griffin; Larry E Davis; Vicki A Morrison; Paula W Annunziato
Journal:  Ann Intern Med       Date:  2010-05-04       Impact factor: 25.391

3.  Efficacy results of a trial of a herpes simplex vaccine.

Authors:  Robert B Belshe; Peter A Leone; David I Bernstein; Anna Wald; Myron J Levin; Jack T Stapleton; Iris Gorfinkel; Rhoda L Ashley Morrow; Marian G Ewell; Abbie Stokes-Riner; Gary Dubin; Thomas C Heineman; Joann M Schulte; Carolyn D Deal
Journal:  N Engl J Med       Date:  2012-01-05       Impact factor: 91.245

Review 4.  Ocular disease associated with Epstein-Barr virus infection.

Authors:  A Y Matoba
Journal:  Surv Ophthalmol       Date:  1990 Sep-Oct       Impact factor: 6.048

5.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

Review 6.  Update on the current status of cytomegalovirus vaccines.

Authors:  Heungsup Sung; Mark R Schleiss
Journal:  Expert Rev Vaccines       Date:  2010-11       Impact factor: 5.217

7.  Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis.

Authors:  B A Barron; L Gee; W W Hauck; N Kurinij; C R Dawson; D B Jones; K R Wilhelmus; H E Kaufman; J Sugar; R A Hyndiuk
Journal:  Ophthalmology       Date:  1994-12       Impact factor: 12.079

8.  Bilateral herpetic keratitis.

Authors:  K R Wilhelmus; M G Falcon; B R Jones
Journal:  Br J Ophthalmol       Date:  1981-06       Impact factor: 4.638

9.  Telemedicine diagnosis of cytomegalovirus retinitis by nonophthalmologists.

Authors:  Michael Yen; Somsanguan Ausayakhun; Jenny Chen; Sakarin Ausayakhun; Choeng Jirawison; David Heiden; Gary N Holland; Todd P Margolis; Jeremy D Keenan
Journal:  JAMA Ophthalmol       Date:  2014-09       Impact factor: 7.389

Review 10.  Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.

Authors:  Thomas J Liesegang
Journal:  Ophthalmology       Date:  2008-02       Impact factor: 12.079

View more
  3 in total

1.  Herpesvirus-Associated Lymphadenitis Distorts Fibroblastic Reticular Cell Microarchitecture and Attenuates CD8 T Cell Responses to Neurotropic Infection in Mice Lacking the STING-IFNα/β Defense Pathways.

Authors:  Derek J Royer; Christopher D Conrady; Daniel J J Carr
Journal:  J Immunol       Date:  2016-08-10       Impact factor: 5.422

Review 2.  The Role of Tissue Resident Memory CD4 T Cells in Herpes Simplex Viral and HIV Infection.

Authors:  Thomas R O'Neil; Kevin Hu; Naomi R Truong; Sana Arshad; Barbara L Shacklett; Anthony L Cunningham; Najla Nasr
Journal:  Viruses       Date:  2021-02-25       Impact factor: 5.048

Review 3.  New Paradigms for the Study of Ocular Alphaherpesvirus Infections: Insights into the Use of Non-Traditional Host Model Systems.

Authors:  Matthew R Pennington; Eric C Ledbetter; Gerlinde R Van de Walle
Journal:  Viruses       Date:  2017-11-18       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.